Pfizer posts late-stage trial wins for vitiligo drug (PFE:NYSE)

Pfizer posts late-stage trial wins for vitiligo drug (PFE:NYSE)  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.